- Intravascular Ultrasound (IVUS)
- Coronary Optical Coherence Tomography (OCT)
- Coronary Intervention: Outcome
- Coronary Intervention: Devices
- Cardiology: Webinar
Show me the data – What is the evidence for routine intravascular imaging
Optimizing PCI (O-PCI) is a series of educational meetings dedicated to helping cardiologists optimize decision-making in interventional cardiac procedures using state-of-the-art intravascular...
Optimizing PCI (O-PCI) is a series of educational meetings dedicated to helping cardiologists optimize decision-making in interventional cardiac procedures using state-of-the-art intravascular imaging and physiology technologies. Our renowned international faculty is committed to help cardiologists master interpretation of invasive diagnostic devices and treat with precision, thus securing optimal outcomes for patients.
Speakers
Kevin Croce
Speaker
Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total... Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program at Brigham and Women’s Hospital (BWH). He is an assistant professor of medicine at Harvard Medical School (HMS) who also directs the BWH Translational Discovery Laboratory which is a centralized research facility that uses state-of-the-art technology to perform preclinical testing of promising therapies and medical devices. Dr. Croce received his medical and Ph.D. degrees from Tufts University School of Medicine. He completed an internal medicine residency, a cardiology fellowship and an interventional cardiology fellowship at BWH. Dr. Croce is board certified in internal medicine, cardiovascular disease and interventional cardiology. His clinical interests include advanced treatments for obstructive coronary artery disease (CAD), and optimization of antithrombotic and antiplatelet pharmacotherapy. The author of over 50 peer-reviewed publications, Dr. Croce’s research focuses on understanding the molecular pathobiology of atherothrombotic (CAD) and on identifying new targets for CAD treatment. His research has received support from the National Institutes of Health.
